Topic Review
Islet β-Cell Death
The loss of β-cells is considered a key to the pathogenesis of both type 1 diabetes (T1D) and T2D.
  • 327
  • 31 Mar 2021
Topic Review
Iron's Altered Metabolism in Cancer
Iron is the most abundant transition metal in the human body and a vital micronutrient that is a critical component of many crucial enzymes. Therefore, it is essential to various biological processes, such as DNA synthesis and repair, cell cycle regulation, transport of oxygen, and energy production. Consequently, it is of no surprise that iron levels elevated in cancer and can lead to further tumour development and metastasis 
  • 558
  • 24 Oct 2022
Topic Review
Iron, Ferroptosis, and Head and Neck Cancer
Ferroptosis is an iron-dependent regulatory form of cell death characterized by the accumulation of intracellular reactive oxygen species and lipid peroxidation. It plays a critical role not only in promoting drug resistance in tumors, but also in shaping therapeutic approaches for various malignancies. 
  • 298
  • 20 Oct 2023
Topic Review
Iron Metabolism and Mechanisms of Ferroptosis
Ferroptosis is a newly discovered iron-dependent form of regulated cell death driven by phospholipid peroxidation and associated with processes including iron overload, lipid peroxidation, and dysfunction of cellular antioxidant systems. Ferroptosis is found to be closely related to many diseases, including cancer at every stage. Epithelial–mesenchymal transition (EMT) in malignant tumors that originate from epithelia promotes cancer-cell migration, invasion, and metastasis by disrupting cell–cell and cell–cell matrix junctions, cell polarity, etc.
  • 232
  • 31 Jul 2023
Topic Review
Iron and Anti-Cancer Immune Response
New insights into the field of iron metabolism within the tumor microenvironment have been uncovered in recent years. Iron promotes the production of reactive oxygen species, which may either trigger ferroptosis cell death or contribute to malignant transformation. Once transformed, cancer cells divert tumor-infiltrating immune cells to satisfy their iron demand, thus affecting the tumor immunosurveillance. In this review, we highlight how the bioavailability of this metal shapes complex metabolic pathways within the tumor microenvironment and how this affects both tumor-associated macrophages and tumor-infiltrating lymphocytes functions. Furthermore, we discuss the potentials as well as the current clinical controversies surrounding the use of iron metabolism as a target for new anticancer treatments in two opposed conditions: (i) the “hot” tumors, which are usually enriched in immune cells infiltration and are extremely rich in iron availability within the microenvironment, and (ii) the “cold” tumors, which are often very poor in immune cells, mainly due to immune exclusion.
  • 664
  • 06 Apr 2021
Topic Review
IPSC-Based PDAC Models and Immunotherapies
Advances in the treatment of pancreatic ductal adenocarcinoma (PDAC) using neoadjuvant chemoradiotherapy, chemotherapy, and immunotherapy have had minimal impact on the overall survival of patients. A general lack of immunogenic features and a complex tumor microenvironment (TME) are likely culprits for therapy refractoriness in PDAC. Induced pluripotent stem cells (iPSCs) should be explored as a means to advance the treatment options for PDAC, by providing representative in vitro models of pancreatic cancer development. In addition, iPSCs could be used for tailor-made cellular immunotherapies or as a source of tumor-associated antigens in the context of vaccination.
  • 506
  • 29 Mar 2022
Topic Review
IPSC Preparation and Epigenetic Memory
The derivation of induced pluripotent stem cells (iPSCs) from somatic human cells by Takahashi and Yamanaka in 2007 represented a turning point for the field. For the first time, they provided isogenic pluripotent cells with the potential for personalized cell replacement therapies; no ethical issues would be created by using the somatic cells. This opportunity marks a decisive step compared to the generation of human embryonic stem cells (ESCs) arranged by Thomson et al. in 1998. The production of induced pluripotent stem cells (iPSCs) represent a breakthrough in regenerative medicine, providing new opportunities for understanding basic molecular mechanisms of human development and molecular aspects of degenerative diseases.
  • 740
  • 22 Jun 2021
Topic Review
Ions and Ion Channels
Life depends upon the ability of cells to evaluate and adapt to a constantly changing environment and to maintain internal stability to allow essential biochemical reactions to occur. Ions and ion channels play a crucial role in this process and are essential for survival. Alterations in the expression of the transmembrane proteins responsible for maintaining ion balance that occur as a result of mutations in the genetic code or in response to iatrogenically induced changes in the extracellular environment is a characteristic feature of oncogenesis and identifies cancer as one of a constellation of diseases known as channelopathies.
  • 315
  • 08 Oct 2022
Topic Review
Ionic Salt Signals
The strong impact that ionic signaling exerts on the immune system is not restricted to T cells. Cellular players from both the innate and adaptive immune compartments are likewise exposed to differential concentrations of ionic signals in the tissue microenvironment. While several pathways have been shown to be conserved across cell types, others will be more cell type specific, leaving room for additional salt effects to be observed in the future.
  • 424
  • 12 Oct 2021
Topic Review
Involvement of Opioid Peptides in Cancer
Peptides mediate cancer progression favoring the mitogenesis, migration, and invasion of tumor cells, promoting metastasis and anti-apoptotic mechanisms, and facilitating angiogenesis/lymphangiogenesis. Tumor cells overexpress peptide receptors, crucial targets for developing specific treatments against cancer cells using peptide receptor antagonists and promoting apoptosis in tumor cells. Opioids exert an antitumoral effect, whereas others promote tumor growth and metastasis. The involvement of opioid peptides in cancer; these peptides have enhanced the tumor growth induced by stress. MET and dynorphin (DYN) A are released from immune cells under inflammatory conditions, and the level of DYN in the cerebrospinal fluid increased in patients with cancer pain. The re-expression of the mu-opioid receptor gene in tumor cells increased the release of beta-endorphin (END) from these cells. Moreover, skin-derived beta-END mediates the fatigue induced by radiation therapy in cancer patients; plasma beta-END level augmented in rats receiving radiation but was reversed with naloxone. 
  • 304
  • 18 Jul 2023
  • Page
  • of
  • 161
ScholarVision Creations